Profile
Peter Halling is currently President & Chief Executive Officer at ALK-Abello A since 2024.
Mr. Halling is also Chief Financial Officer at Fertin Pharma A since 2020.
Mr. Halling graduated from Copenhagen Business School.
Peter Halling active positions
| Companies | Position | Start |
|---|---|---|
| ALK-ABELLÓ A/S | Chief Executive Officer | 2023-12-31 |
Fertin Pharma A/S
Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Develops and manufactures medical chewing gum products | Director of Finance/CFO | - |
Training of Peter Halling
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
ALK-Abello A/S
ALK-Abello A/S Pharmaceuticals: MajorHealth Technology Develops and produces, markets products for diagnosing, treating allergies, allergic asthma & acute anaphylactic reactions | Health Technology |
Copenhagen Business School
Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fertin Pharma A/S
Fertin Pharma A/S Food: Specialty/CandyConsumer Non-Durables Develops and manufactures medical chewing gum products | Consumer Non-Durables |
- Stock Market
- Insiders
- Peter Halling
















